MindPlexaは、アイデアを実行可能なプロジェクトに変えるAI搭載の生産性プラットフォームです。視覚的なマインドマッピングとインテリジェントなプロジェクト管理を組み合わせ、直感的なキャンバスとスマートノードを使用してアイデアを作成、整理、共同作業できます。AIアシスタントがプロジェクトのレイアウト生成、タスク提案、ワークフローの効率化を支援し、創造性と効率を高めたいチームや個人に最適なツールです。
製品概要
MindPlexa 製品概要
MindPlexaは、アイデアを実行可能なプロジェクトに変えるAI搭載の生産性プラットフォームです。視覚的なマインドマッピングとインテリジェントなプロジェクト管理を組み合わせ、直感的なキャンバスとスマートノードを使用してアイデアを作成、整理、共同作業できます。AIアシスタントがプロジェクトのレイアウト生成、タスク提案、ワークフローの効率化を支援し、創造性と効率を高めたいチームや個人に最適なツールです。
Shram 製品概要
Shramは、ゲーミフィケーションを通じてチームの生産性を向上させる、楽しいAI搭載の業務管理プラットフォームです。タスクをインテリジェントに割り当て、パフォーマンスを追跡し、実用的なインサイトを提供することで、分散型チームの仕事をより魅力的で楽しいものにします。
Detailed feature comparison
MindPlexa vs Shram monthly traffic
Compare MindPlexa and Shram by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the MindPlexa vs Shram monthly traffic comparison, MindPlexa currently shows 3.4K visits and Shram shows 1.9K; MindPlexa has about 1.8 times the visible traffic of Shram, an absolute difference of about 1.5K visits. This reflects visible reach, not feature quality or paid users.
Only Shram has complete third-party traffic details; MindPlexa uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
MindPlexa monthly traffic:
Latest traffic
Shram monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 1.4K 月間訪問数
- 2026/1: 2.3K 月間訪問数
- 2026/2: 2.2K 月間訪問数
- 2026/3: 1.7K 月間訪問数
- 2026/4: 1.3K 月間訪問数
- 2026/5: 1.9K 月間訪問数
主要地域
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇮🇳India | 100% | 1.9K |
検索キーワード
Usage comparison
Compare the core capabilities of MindPlexa and Shram
MindPlexa Core features
Shram Core features
Use cases
MindPlexa Use cases
Shram Use cases
Best suited roles
MindPlexa Best suited roles
Shram Best suited roles
MindPlexa vs Shram:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth MindPlexa vs Shram comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. MindPlexa is primarily listed under “チームワーク”, while Shram is primarily listed under “生産性”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (MindPlexa: チームワーク; Shram: 生産性); Monthly visits (MindPlexa: 3.4K; Shram: 1.9K); Favorites (MindPlexa: 114; Shram: 102); Website (MindPlexa: www.mindplexa.com; Shram: shram.io); Added (MindPlexa: 2025-09-22; Shram: 2025-09-19). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the MindPlexa vs Shram monthly traffic comparison, MindPlexa currently shows 3.4K visits and Shram shows 1.9K; MindPlexa has about 1.8 times the visible traffic of Shram, an absolute difference of about 1.5K visits. This reflects visible reach, not feature quality or paid users.
Only Shram has complete third-party traffic details; MindPlexa uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Product positioning, use cases, and roles
MindPlexa and Shram currently overlap in shared categories: プロジェクト管理、タスク管理; shared tags: AIアシスタント、タスク管理、チームコラボレーション; shared roles: マーケティングマネージャー、プロダクトマネージャー、プロジェクトマネージャー、ソフトウェア開発者、チームリーダー. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
MindPlexa's unique categories/tags are チームワーク、マインドマッピング、ブレインストーミング、コラボレーション、アイデア管理、生産性、プロジェクト管理、視覚的ワークスペース; Shram's are 生産性、業績管理、AIプロジェクト管理、ゲーミフィケーション、パフォーマンス追跡、生産性ツール、チームエンゲージメント、ワークロードバランシング. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
MindPlexa has no verified rating, 0 comments, 114 favorites, and 96 likes;Shram has no verified rating, 0 comments, 102 favorites, and 100 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate MindPlexa first
Put MindPlexa on the priority trial list when the task aligns with “チームワーク” and especially チームワーク、マインドマッピング、ブレインストーミング、コラボレーション、アイデア管理、生産性, or the users include ビジネスストラテジスト、コンサルタント、コンテンツクリエイター、創業者. This follows recorded positioning and does not imply unlisted capabilities are absent.
MindPlexa also currently records: pricing is freemium, product type is website, 3.4K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate Shram first
Put Shram on the priority trial list when the task aligns with “生産性” and especially 生産性、業績管理、AIプロジェクト管理、ゲーミフィケーション、パフォーマンス追跡、生産性ツール, or the users include 建築家、最高経営責任者、グラフィックデザイナー、人事マネージャー. This follows recorded positioning and does not imply unlisted capabilities are absent.
Shram also currently records: pricing is freemium, product type is website, 1.9K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in MindPlexa and Shram, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




